Literature DB >> 18216371

Spill and leakage using a drug preparation system based on double-filter technology.

Olle Nygren1, Eva Olofsson, Lennart Johansson.   

Abstract

Occupational exposure to cytotoxic drugs has frequently been reported during recent years. Various drug-handling systems have been applied to reduce the spill and leakage that cause this exposure. Some of these systems have also been tested for spill and leakage using independent test methods. In this paper, a new drug-handling system has been tested for spill and leakage during drug preparation. The handling system, Tevadaptortrade mark, was tested using a modification of an independent test method, the Technetium test method, based on the use of Technetium m-99 as tracer substance. The test results showed that the spill was <100 nl for all 75 preparations and was <1 nl for 70 of the preparations. This is comparable with other tested drug-handling system, e.g. isolators, PhaSealtrade mark. The test shows that the Tevadaptor drug-handling system has similar performance as drug-handling systems regarded as closed systems.

Mesh:

Substances:

Year:  2008        PMID: 18216371     DOI: 10.1093/annhyg/mem067

Source DB:  PubMed          Journal:  Ann Occup Hyg        ISSN: 0003-4878


  8 in total

1.  NIOSH definition of closed-system drug-transfer devices.

Authors:  Olle Nygren; Eva Olofsson; Lennart Johannson
Journal:  Ann Occup Hyg       Date:  2009-05-27

2.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

Review 3.  Identification of Knowledge Gaps Regarding Healthcare Workers' Exposure to Antineoplastic Drugs: Review of Literature, North America versus Europe.

Authors:  Chun-Yip Hon; Cris Barzan; George Astrakianakis
Journal:  Saf Health Work       Date:  2014-06-11

4.  Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study.

Authors:  Nicolas Simon; Michèle Vasseur; Marine Pinturaud; Marion Soichot; Camille Richeval; Luc Humbert; Michèle Lebecque; Ousseini Sidikou; Christine Barthelemy; Pascal Bonnabry; Delphine Allorge; Bertrand Décaudin; Pascal Odou
Journal:  PLoS One       Date:  2016-07-08       Impact factor: 3.240

5.  Source apportionment and quantification of liquid and headspace leaks from closed system drug-transfer devices via Selected Ion Flow Tube Mass Spectrometry (SIFT-MS).

Authors:  Amos Doepke; Robert P Streicher
Journal:  PLoS One       Date:  2021-11-04       Impact factor: 3.240

Review 6.  Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff.

Authors:  Kurinchi Selvan Gurusamy; Lawrence Mj Best; Cynthia Tanguay; Elaine Lennan; Mika Korva; Jean-François Bussières
Journal:  Cochrane Database Syst Rev       Date:  2018-03-27

7.  Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs.

Authors:  Alan-Shaun Wilkinson; Michael Charles Allwood; Colin Patrick Morris; Andrew Wallace; Rebecca Finnis; Ewelina Kaminska; Donata Stonkute; Maja Szramowska; Joe Miller; Ian Pengelly; Michael Hemingway
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

8.  Validation of chemotherapy drug vapor containment of an air cleaning closed-system drug transfer device.

Authors:  Galit Levin; Paul Jm Sessink
Journal:  J Oncol Pharm Pract       Date:  2021-07-06       Impact factor: 1.416

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.